Approval · Notice of Compliance 23178 · 2020
DILTIAZEM CD: Notice of Compliance 23178
Issued February 4, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23178
- Date
- February 4, 2020
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Labelling update to match licensor
- Canadian reference product
- CARDIZEM CD (Valeant Canada Lp)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DILTIAZEM CD | Not yet assigned | — |
Medicinal ingredients
- DILTIAZEM HCL 120 MG per CAP
- DILTIAZEM HCL 180 MG per CAP
- DILTIAZEM HCL 240 MG per CAP
- DILTIAZEM HCL 300 MG per CAP